• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$62.98
+0 (0.00%)
Get New M.D.C. Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDC

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for M.D.C. in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $62.98.

This chart shows the closing price for MDC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in M.D.C.. This rating has held steady since February 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/7/2024Raymond James FinancialReiterated RatingOutperform ➝ Market Perform
1/31/2024Evercore ISIDowngradeOutperform ➝ In-Line$57.00 ➝ $63.00
12/1/2023Raymond James FinancialLower TargetOutperform ➝ Outperform$60.00 ➝ $55.00
11/2/2023JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight$41.50 ➝ $39.50
8/3/2023Raymond James FinancialBoost TargetOutperform ➝ Outperform$55.00 ➝ $60.00
7/31/2023WedbushBoost TargetNeutral ➝ Neutral$28.00 ➝ $51.00
7/14/2023Raymond James FinancialUpgradeMarket Perform ➝ Outperform$55.00
6/14/2023Seaport Res PtnReiterated RatingNeutral
3/6/2023JPMorgan Chase & Co.Lower TargetUnderweight$30.50 ➝ $27.50
2/7/2023WedbushReiterated RatingNeutral
11/22/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$27.00 ➝ $28.00
11/4/2022WedbushLower Target$28.00
11/3/2022JPMorgan Chase & Co.Lower TargetNeutral$31.50 ➝ $27.00
10/21/2022Raymond James FinancialDowngradeStrong-Buy ➝ Market Perform
7/12/2022JPMorgan Chase & Co.Lower TargetNeutral$40.50 ➝ $38.00
6/17/2022Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$27.00
4/13/2022JPMorgan Chase & Co.Lower TargetNeutral$49.00 ➝ $39.00
3/10/2022JPMorgan Chase & Co.Lower TargetNeutral$66.00 ➝ $49.00
2/1/2022WedbushReiterated RatingNeutral
11/8/2021Raymond James FinancialLower TargetStrong-Buy$79.00 ➝ $77.00
10/14/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$66.00
8/19/2021Raymond James FinancialLower TargetStrong-Buy$80.00 ➝ $79.00
4/21/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$65.00
4/15/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$65.00
3/18/2021Bank of AmericaReiterated RatingNeutral ➝ Underperform$63.00
3/16/2021Wolfe ResearchInitiated CoveragePeer Perform
3/12/2021Bank of AmericaDowngradeNeutral ➝ Underperform$63.00
1/25/2021Raymond James FinancialBoost TargetStrong-Buy$61.00 ➝ $71.00
1/5/2021Bank of AmericaDowngradeBuy ➝ Neutral
(Data available from 12/5/2020 forward)

News Sentiment Rating

-0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2025
  • 4 very positive mentions
  • 42 positive mentions
  • 13 negative mentions
  • 16 very negative mentions
8/6/2025
  • 1 very positive mentions
  • 24 positive mentions
  • 7 negative mentions
  • 9 very negative mentions
9/5/2025
  • 5 very positive mentions
  • 20 positive mentions
  • 5 negative mentions
  • 3 very negative mentions
10/5/2025
  • 3 very positive mentions
  • 17 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
11/4/2025
  • 8 very positive mentions
  • 23 positive mentions
  • 8 negative mentions
  • 17 very negative mentions
12/4/2025

Current Sentiment

  • 8 very positive mentions
  • 23 positive mentions
  • 8 negative mentions
  • 17 very negative mentions

Recent Stories by Sentiment

M.D.C. logo
M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, Washington, Colorado, Idaho, Utah, Alabama, Florida, Maryland, Pennsylvania, Tennessee, and Virginia. Its financial services operations comprise originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, Pennsylvania, and Virginia. The company was founded in 1972 and is headquartered in Denver, Colorado. As of April 19, 2024, M.D.C. Holdings, Inc. operates as a subsidiary of SH Residential Holdings, LLC.
Read More

Today's Range

Now: $62.98
Low: $62.98
High: $62.98

50 Day Range

MA: $62.92
Low: $62.62
High: $62.98

52 Week Range

Now: $62.98
Low: $36.47
High: $63.00

Volume

N/A

Average Volume

1,973,656 shs

Market Capitalization

$4.73 billion

P/E Ratio

11.93

Dividend Yield

3.49%

Beta

1.54

Frequently Asked Questions

What sell-side analysts currently cover shares of M.D.C.?

The following equities research analysts have issued research reports on M.D.C. in the last twelve months: Wall Street Zen.
View the latest analyst ratings for MDC.

What is the current price target for M.D.C.?

0 Wall Street analysts have set twelve-month price targets for M.D.C. in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for M.D.C. in the next year.
View the latest price targets for MDC.

What is the current consensus analyst rating for M.D.C.?

M.D.C. currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MDC.

What other companies compete with M.D.C.?

How do I contact M.D.C.'s investor relations team?

M.D.C.'s physical mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company's listed phone number is (303) 773-1100 and its investor relations email address is [email protected]. The official website for M.D.C. is www.mdcholdings.com. Learn More about contacing M.D.C. investor relations.